The Chemours Company (CC) AI Stock Analysis

The Chemours Company provides performance chemicals across North America, Asia Pacific, Europe, Middle East, Africa, and Latin America. It operates through four segments: Titanium Technologies, which produces TiO2 pigment brands Ti-Pure and BaiMax for coatings, plastics, and packaging; Thermal & Specialized Solutions, which offers refrigerants, thermal management solutions, propellants, foam blowing agents, and specialty solvents; Advanced Performance Materials, which supplies industrial resins, specialty products, membranes, and coatings; and Chemical Solutions, which delivers industrial chemicals used as raw materials and catalysts in mining, water treatment, and electronics.

Revenue at Chemours grew from $6.34B in FY2021 to $6.83B in FY2022, before declining to $6.08B in FY2023 and $5.78B in FY2024. In FY2025, revenue rose 0.4% to $5.81B, while gross margin fell to 15.5% and net income was -$386.0M. From FY2020 to FY2025, revenue registered a 5-year CAGR of 3.2%. For the latest quarter ended June 30, 2026, revenue fell 1.5% year-over-year, and quarterly earnings declined 64.6%. Over the trailing twelve months, operating margin was 1.1% and return on equity stood at -319.4%.

As of June 30, 2026, Chemours held $671.0M in cash and short-term investments against $4.12B in total debt, resulting in net debt of $3.45B. Shareholders' equity was -$49.0M, reflecting negative equity, while the current ratio was 1.66. In FY2025, the company produced $264.0M in operating cash flow and $51.0M in free cash flow. Capital allocation in FY2025 included $213.0M for capital expenditures, $78.0M for dividends paid, and $1.0M for share buybacks.

Chemours trades at a forward P/E of 7.3x, below the 13.4x median of its US-listed Basic Materials peers. Its EV to EBITDA ratio is 10.5x, matching the US-listed Basic Materials peer median of 10.5x, while its price-to-sales ratio is 0.3x versus the peer median of 1.8x. Over the past year, Chemours shares declined 5.4%, trailing the S&P 500 return of 16.8%. Over five years, the stock fell 51.2%, compared to an 83.0% gain for the S&P 500.

Chemours pays a forward annual dividend of $0.35 per share, representing a dividend yield of 2.75% and a payout ratio of 48.9%. Dividends are distributed quarterly and have been paid for 12 consecutive years. The annualized five-year dividend growth rate is -12.5%. The last ex-dividend date was August 14, 2026.

Wall Street analysts hold 2 Strong Buy and 8 Hold ratings on Chemours, with no Buy, Sell, or Strong Sell recommendations. The mean price target is $16.90, which is 32.7% above the last closing price of $12.74. For the fiscal year ending December 31, 2026, analysts estimate revenue of $5.92B and EPS of $0.95. Chemours beat EPS estimates in 1 of the last 4 quarters, and its next earnings date is November 5, 2026.

This page is an AI-written research summary of The Chemours Company (CC). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.

Related: CC income statement, CC balance sheet, CC key metrics, CC analyst forecast, CC chart. See the CC stock overview for the latest quote and news.